When the model drifts and the trail stays silent
This week’s AI governance talk in GxP did what it always does when policy people outnumber operators: it made a hard engineering problem sound like a memo. The real issue is not whether someone can write a policy that nods at 21 CFR Part 11, validation, and oversight in the right sequence; it is whether the model, the data, the logs, the release process, and the quality system actually agree on what happened and when.
The stakes are not theoretical. FDA is already seeing a substantial uptick in drug applications that incorporate AI components across discovery and manufacturing. Once AI is in the submission path or the plant floor, governance stops being a slide deck exercise and becomes part of the evidence chain.
The reader frustration is justified
If you work in regulated engineering, you have heard some version of the system is validated so often it has stopped meaning anything precise. Sometimes it means the software passed testing. Sometimes it means the team documented the pain carefully enough to survive an audit. In AI, that phrase gets even thinner, because governance is often treated like a policy wrapper instead of an engineering discipline. The document says “controlled,” while the model keeps learning, drifting, or emitting outputs nobody can reconstruct with confidence.
That is not a compliance philosophy problem. It is a systems problem. And the people closest to it are usually the ones left cleaning up the interface between the data science notebook, the MES or LIMS, the quality vault, and the electronic record system that is supposed to make the evidence chain real.
Why adoption is hard in the actual plant, lab, or trial stack
AI models do not behave like static validated applications. They change with retraining, prompt updates, upstream data shifts, feature engineering changes, and vendor service releases. Conventional change control was built for bounded software changes, not for models whose behavior can move without a clean event quality can see.
That is the engineering gap. 21 CFR Part 11 cares about trustworthy electronic records and signatures, but it does not magically solve whether your AI inference output is attributable, timestamped, retained, and traceable to the exact model and data state that produced it. If your governance stack cannot answer that, the policy binder is not the control. It is decoration.
This is also why pharma companies keep buying more compute, more platforms, and more layers of “enablement” without clearing the core problem. AI is spreading from discovery into legal, manufacturing, and marketing because the enterprise wants leverage. But in GxP, leverage without traceability is just a faster way to lose the trail.
What failure looks like when the audit arrives
Picture the room: a validation lead, a QA reviewer, a data engineer, and one exhausted systems owner staring at a deviation because the AI tool helped classify a batch issue, but nobody can prove which training set produced that recommendation. The model passed validation six weeks ago. The audit fails today because the training data was not versioned, the inference outputs were not logged in a durable system, and the handoff between the model service and the GxP record system broke in exactly the place everyone hoped would be “handled downstream.”
That is the kind of failure people politely call an alignment issue. In practice, it is a broken evidence chain. The model may be excellent; the system around it is not. And when the electronic trail cannot answer basic questions, which data, which model, which threshold, which user action, which timestamp, which approved release, the audit does not care how elegant the slide deck was.
This is where compliance software earns its keep or reveals itself as expensive fiction. If the MLOps stack, the eQMS, the data lake, and the document management system do not share a coherent identity and traceability scheme, then version control is theater. The trail is only as real as the worst handoff.
The systems implication nobody can policy away
AI governance in GxP is model risk, not just policy. That means owning the full chain: data provenance, model versioning, inference logging, access control, release approval, performance monitoring, drift detection, and the procedure for what happens when the model’s behavior changes before the document set does. It also means admitting that interoperability is not a slide. It is the outcome.
There is a reason software teams keep surfacing in this story. Platforms like PolyModels Hub are trying to digitise pharmacology workflows, which is a reminder that the real product is not “AI” in the abstract but the software that carries scientific work from one state to the next. If that software cannot preserve state, provenance, and accountability, it is not helping science. It is just compressing the time to confusion.
Marina will disagree with the pace, Daniel would call it an API problem, and both would be right in the narrow way people are right when they have spent too long looking at clean diagrams. In the field, the diagram is never the failure. The unowned interface is.
When your AI model drifts but your audit trail doesn’t log it, is it a model problem or a governance gap?
email: hello@example.com